GlycoMimetics Appoints Tim Pearson to Board of Directors and as Audit Committee Chair
- Pearson, former CFO of
"Having completed our initial public offering in early 2014, it's ideal
for us to now be adding an experienced public company CFO to our Board
roster," said
"Following GlycoMimetics' IPO and as the company prepares to bring its
lead oncology program into the clinic, it's a great opportunity for me
to join the Board of Directors and to help the company push forward in
achieving its objectives," said
About
bhahn@glycomimetics.com
Source:
News Provided by Acquire Media